Heart failure after myocardial infarction: incidence and predictors

AIMS: The aim of the present paper was to provide an up‐to‐date view on epidemiology and risk factors of heart failure (HF) development after myocardial infarction. METHODS AND RESULTS: Based on literature review, several clinical risk factors and biochemical, genetic, and imaging biomarkers were id...

Descripción completa

Detalles Bibliográficos
Autores principales: Jenča, Dominik, Melenovský, Vojtěch, Stehlik, Josef, Staněk, Vladimír, Kettner, Jiří, Kautzner, Josef, Adámková, Věra, Wohlfahrt, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835562/
https://www.ncbi.nlm.nih.gov/pubmed/33319509
http://dx.doi.org/10.1002/ehf2.13144
Descripción
Sumario:AIMS: The aim of the present paper was to provide an up‐to‐date view on epidemiology and risk factors of heart failure (HF) development after myocardial infarction. METHODS AND RESULTS: Based on literature review, several clinical risk factors and biochemical, genetic, and imaging biomarkers were identified to predict the risk of HF development after myocardial infarction. CONCLUSIONS: Heart failure is still a frequent complication of myocardial infarction. Timely identification of subjects at risk for HF development using a multimodality approach, and early initiation of guideline‐directed HF therapy in these patients, can decrease the HF burden.

Ejemplares similares